The Pharmaceutical Sector is at Default Risk. A Proposal to Re-Establish the Economic Balance and Define a New Governance
DOI:
https://doi.org/10.33393/grhta.2015.324Keywords:
Drug expenditure, Formulary governance, Pharmaceutical sectorAbstract
The pharmaceutical governance in Italy is provided by a cap applied as a percentage of the National Health Fund to the territorial (11.35%) and hospital expenditure (3.5%). The amount of overspending is charged to the pharmaceutical companies with a payback procedure. For the years 2014-2016 the overspending is estimated at about 3.8 billion euros, which is likely to result in a system default. In this article a new pharmaceutical governance is proposed and discussed; its aim is to avoid financial imbalance and to identify appropriate measures to bridge the gap between the very high prices of new/innovative drugs and the system sustainability.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 The Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to Global & Regional Health Technology Assessment agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.
Accepted 2023-06-27
Published 2015-03-17
